Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis

Authors: Freddie Bwanga, Sven Hoffner, Melles Haile, Moses L Joloba

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

One of the challenges facing the tuberculosis (TB) control programmes in resource-limited settings is lack of rapid techniques for detection of drug resistant TB, particularly multi drug resistant tuberculosis (MDR TB). Results obtained with the conventional indirect susceptibility testing methods come too late to influence a timely decision on patient management. More rapid tests directly applied on sputum samples are needed. This study compared the sensitivity, specificity and time to results of four direct drug susceptibility testing tests with the conventional indirect testing for detection of resistance to rifampicin and isoniazid in M. tuberculosis. The four direct tests included two in-house phenotypic assays – Nitrate Reductase Assay (NRA) and Microscopic Observation Drug Susceptibility (MODS), and two commercially available tests – Genotype® MTBDR and Genotype® MTBDRplus (Hain Life Sciences, Nehren, Germany).

Methods

A literature review and meta-analysis of study reports was performed. The Meta-Disc software was used to analyse the reports and tests for sensitivity, specificity, and area under the summary receiver operating characteristic (sROC) curves. Heterogeneity in accuracy estimates was tested with the Spearman correlation coefficient and Chi-square.

Results

Eighteen direct DST reports were analysed: NRA – 4, MODS- 6, Genotype MTBDR® – 3 and Genotype® MTBDRplus – 5. The pooled sensitivity and specificity for detection of resistance to rifampicin were 99% and 100% with NRA, 96% and 96% with MODS, 99% and 98% with Genotype® MTBDR, and 99% and 99% with the new Genotype® MTBDRplus, respectively. For isoniazid it was 94% and 100% for NRA, 92% and 96% for MODS, 71% and 100% for Genotype® MTBDR, and 96% and 100% with the Genotype® MTBDRplus, respectively. The area under the summary receiver operating characteristic (sROC) curves was in ranges of 0.98 to 1.00 for all the four tests. Molecular tests were completed in 1 – 2 days and also the phenotypic assays were much more rapid than conventional testing.

Conclusion

Direct testing of rifampicin and isoniazid resistance in M. tuberculosis was found to be highly sensitive and specific, and allows prompt detection of MDR TB.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: Global tuberculosis control 2008: surveillance, planning, financing. Geneva, Switzerland: World Health Organization; Publication no. WHO/HTM/TB/2008.393). 2008 WHO: Global tuberculosis control 2008: surveillance, planning, financing. Geneva, Switzerland: World Health Organization; Publication no. WHO/HTM/TB/2008.393). 2008
2.
go back to reference WHO/IUATLD: Global Project on Anti-Tuberculosis Drug Resistance Surveillance: Anti-Tuberculosis drug resistance in the world, Report No.4, Annex 9. WHO/HTM/TB/2008.394 Geneva. 2008 WHO/IUATLD: Global Project on Anti-Tuberculosis Drug Resistance Surveillance: Anti-Tuberculosis drug resistance in the world, Report No.4, Annex 9. WHO/HTM/TB/2008.394 Geneva. 2008
3.
go back to reference Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003, 167 (4): 603-662. 10.1164/rccm.167.4.603.CrossRefPubMed Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003, 167 (4): 603-662. 10.1164/rccm.167.4.603.CrossRefPubMed
4.
go back to reference Woods GL: Susceptibility testing for mycobacteria. Clin Infect Dis. 2000, 31 (5): 1209-1215. 10.1086/317441.CrossRefPubMed Woods GL: Susceptibility testing for mycobacteria. Clin Infect Dis. 2000, 31 (5): 1209-1215. 10.1086/317441.CrossRefPubMed
5.
go back to reference Angeby KA, Klintz L, Hoffner SE: Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol. 2002, 40 (2): 553-555. 10.1128/JCM.40.2.553-555.2002.CrossRefPubMedPubMedCentral Angeby KA, Klintz L, Hoffner SE: Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol. 2002, 40 (2): 553-555. 10.1128/JCM.40.2.553-555.2002.CrossRefPubMedPubMedCentral
6.
go back to reference Affolabi D, Odoun M, Sanoussi N, Martin A, Palomino JC, Kestens L, Anagonou S, Portaels F: Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples. J Clin Microbiol. 2008, 46 (10): 3243-3245. 10.1128/JCM.00083-08.CrossRefPubMedPubMedCentral Affolabi D, Odoun M, Sanoussi N, Martin A, Palomino JC, Kestens L, Anagonou S, Portaels F: Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples. J Clin Microbiol. 2008, 46 (10): 3243-3245. 10.1128/JCM.00083-08.CrossRefPubMedPubMedCentral
7.
go back to reference Affolabi D, Odoun M, Martin A, Palomino JC, Anagonou S, Portaels F: Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin. J Clin Microbiol. 2007, 45 (7): 2123-2125. 10.1128/JCM.00691-07.CrossRefPubMedPubMedCentral Affolabi D, Odoun M, Martin A, Palomino JC, Anagonou S, Portaels F: Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin. J Clin Microbiol. 2007, 45 (7): 2123-2125. 10.1128/JCM.00691-07.CrossRefPubMedPubMedCentral
8.
go back to reference Solis LA, Shin SS, Han LL, Llanos F, Stowell M, Sloutsky A: Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru. Int J Tuberc Lung Dis. 2005, 9 (7): 760-764.PubMed Solis LA, Shin SS, Han LL, Llanos F, Stowell M, Sloutsky A: Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru. Int J Tuberc Lung Dis. 2005, 9 (7): 760-764.PubMed
9.
go back to reference Musa HR, Ambroggi M, Souto A, Angeby KA: Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J Clin Microbiol. 2005, 43 (7): 3159-3161. 10.1128/JCM.43.7.3159-3161.2005.CrossRefPubMedPubMedCentral Musa HR, Ambroggi M, Souto A, Angeby KA: Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J Clin Microbiol. 2005, 43 (7): 3159-3161. 10.1128/JCM.43.7.3159-3161.2005.CrossRefPubMedPubMedCentral
10.
go back to reference Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E: Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008, 12 (3): 332-337.PubMed Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E: Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008, 12 (3): 332-337.PubMed
11.
go back to reference Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al: Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006, 355 (15): 1539-1550. 10.1056/NEJMoa055524.CrossRefPubMedPubMedCentral Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al: Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006, 355 (15): 1539-1550. 10.1056/NEJMoa055524.CrossRefPubMedPubMedCentral
12.
go back to reference Brady MF, Coronel J, Gilman RH, Moore DA: The MODS methodfor diagnosis of tuberculosis and multidrug resistant tuberculosis. J Vis Exp. 2008, 17 (17): Brady MF, Coronel J, Gilman RH, Moore DA: The MODS methodfor diagnosis of tuberculosis and multidrug resistant tuberculosis. J Vis Exp. 2008, 17 (17):
13.
go back to reference Mello FC, Arias MS, Rosales S, Marsico AG, Pavon A, Alvarado-Galvez C, Pessoa CL, Perez M, Andrade MK, Kritski AL, et al: Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007, 45 (10): 3387-3389. 10.1128/JCM.00580-07.CrossRefPubMedPubMedCentral Mello FC, Arias MS, Rosales S, Marsico AG, Pavon A, Alvarado-Galvez C, Pessoa CL, Perez M, Andrade MK, Kritski AL, et al: Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007, 45 (10): 3387-3389. 10.1128/JCM.00580-07.CrossRefPubMedPubMedCentral
14.
go back to reference Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E: Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2007, 45 (4): 1093-1097. 10.1128/JCM.01949-06.CrossRefPubMedPubMedCentral Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E: Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2007, 45 (4): 1093-1097. 10.1128/JCM.01949-06.CrossRefPubMedPubMedCentral
15.
go back to reference Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, et al: Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004, 42 (10): 4432-4437. 10.1128/JCM.42.10.4432-4437.2004.CrossRefPubMedPubMedCentral Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, et al: Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004, 42 (10): 4432-4437. 10.1128/JCM.42.10.4432-4437.2004.CrossRefPubMedPubMedCentral
16.
go back to reference Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, Lee EH, Berg DE, Montenegro-James S: Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol. 2000, 38 (3): 1203-1208.PubMedPubMedCentral Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, Lee EH, Berg DE, Montenegro-James S: Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol. 2000, 38 (3): 1203-1208.PubMedPubMedCentral
17.
go back to reference Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S: Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2005, 43 (8): 3699-3703. 10.1128/JCM.43.8.3699-3703.2005.CrossRefPubMedPubMedCentral Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S: Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2005, 43 (8): 3699-3703. 10.1128/JCM.43.8.3699-3703.2005.CrossRefPubMedPubMedCentral
18.
go back to reference Hillemann D, Rusch-Gerdes S, Richter E: Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. Journal of clinical microbiology. 2007, 45 (8): 2635-2640. 10.1128/JCM.00521-07.CrossRefPubMedPubMedCentral Hillemann D, Rusch-Gerdes S, Richter E: Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. Journal of clinical microbiology. 2007, 45 (8): 2635-2640. 10.1128/JCM.00521-07.CrossRefPubMedPubMedCentral
19.
go back to reference Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M: Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol. 2006, 44 (12): 4459-4463. 10.1128/JCM.01506-06.CrossRefPubMedPubMedCentral Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M: Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol. 2006, 44 (12): 4459-4463. 10.1128/JCM.01506-06.CrossRefPubMedPubMedCentral
20.
go back to reference Hillemann D, Rusch-Gerdes S, Richter E: Application of the Genotype MTBDR assay directly on sputum specimens. Int J Tuberc Lung Dis. 2006, 10 (9): 1057-1059.PubMed Hillemann D, Rusch-Gerdes S, Richter E: Application of the Genotype MTBDR assay directly on sputum specimens. Int J Tuberc Lung Dis. 2006, 10 (9): 1057-1059.PubMed
21.
go back to reference Causse M, Ruiz P, Gutierrez JB, Zerolo J, Casal M: Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2008, 12 (12): 1456-1460.PubMed Causse M, Ruiz P, Gutierrez JB, Zerolo J, Casal M: Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2008, 12 (12): 1456-1460.PubMed
22.
go back to reference Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, Roses S, Maldonado J, Dominguez J: GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2008, 46 (11): 3660-3667. 10.1128/JCM.00618-08.CrossRefPubMedPubMedCentral Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, Roses S, Maldonado J, Dominguez J: GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2008, 46 (11): 3660-3667. 10.1128/JCM.00618-08.CrossRefPubMedPubMedCentral
23.
go back to reference Miotto P, Piana F, Cirillo DM, Migliori GB: Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2008, 46 (1): 393-394. 10.1128/JCM.01066-07.CrossRefPubMed Miotto P, Piana F, Cirillo DM, Migliori GB: Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2008, 46 (1): 393-394. 10.1128/JCM.01066-07.CrossRefPubMed
24.
go back to reference Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME: Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008, 177 (7): 787-792. 10.1164/rccm.200709-1436OC.CrossRefPubMed Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME: Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008, 177 (7): 787-792. 10.1164/rccm.200709-1436OC.CrossRefPubMed
25.
go back to reference Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, Meulen van der JH, Bossuyt PM: Empirical evidence of design-related bias in studies of diagnostic tests. Jama. 1999, 282 (11): 1061-1066. 10.1001/jama.282.11.1061.CrossRefPubMed Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, Meulen van der JH, Bossuyt PM: Empirical evidence of design-related bias in studies of diagnostic tests. Jama. 1999, 282 (11): 1061-1066. 10.1001/jama.282.11.1061.CrossRefPubMed
26.
go back to reference Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003, 3: 25-10.1186/1471-2288-3-25.CrossRefPubMedPubMedCentral Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003, 3: 25-10.1186/1471-2288-3-25.CrossRefPubMedPubMedCentral
27.
go back to reference Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A: Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006, 6: 31-10.1186/1471-2288-6-31.CrossRefPubMedPubMedCentral Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A: Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006, 6: 31-10.1186/1471-2288-6-31.CrossRefPubMedPubMedCentral
28.
go back to reference Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino JC, Angeby K: The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother. 2008, 62 (1): 56-64. 10.1093/jac/dkn139.CrossRefPubMed Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino JC, Angeby K: The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother. 2008, 62 (1): 56-64. 10.1093/jac/dkn139.CrossRefPubMed
29.
go back to reference Ling DI, Zwerling AA, Pai M: GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008, 32 (5): 1165-1174. 10.1183/09031936.00061808.CrossRefPubMed Ling DI, Zwerling AA, Pai M: GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008, 32 (5): 1165-1174. 10.1183/09031936.00061808.CrossRefPubMed
30.
go back to reference Morgan M, Kalantri S, Flores L, Pai M: A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2005, 5: 62-10.1186/1471-2334-5-62.CrossRefPubMedPubMedCentral Morgan M, Kalantri S, Flores L, Pai M: A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2005, 5: 62-10.1186/1471-2334-5-62.CrossRefPubMedPubMedCentral
31.
go back to reference Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, Mosteller F: Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994, 120 (8): 667-676.CrossRefPubMed Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, Mosteller F: Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994, 120 (8): 667-676.CrossRefPubMed
32.
go back to reference Littenberg B, Moses LE: Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making. 1993, 13 (4): 313-321. 10.1177/0272989X9301300408.CrossRefPubMed Littenberg B, Moses LE: Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making. 1993, 13 (4): 313-321. 10.1177/0272989X9301300408.CrossRefPubMed
33.
go back to reference Moses LE, Shapiro D, Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993, 12 (14): 1293-1316. 10.1002/sim.4780121403.CrossRefPubMed Moses LE, Shapiro D, Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993, 12 (14): 1293-1316. 10.1002/sim.4780121403.CrossRefPubMed
34.
go back to reference Lijmer JG, Bossuyt PM, Heisterkamp SH: Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med. 2002, 21 (11): 1525-1537. 10.1002/sim.1185.CrossRefPubMed Lijmer JG, Bossuyt PM, Heisterkamp SH: Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med. 2002, 21 (11): 1525-1537. 10.1002/sim.1185.CrossRefPubMed
35.
go back to reference Walter SD: Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002, 21 (9): 1237-1256. 10.1002/sim.1099.CrossRefPubMed Walter SD: Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002, 21 (9): 1237-1256. 10.1002/sim.1099.CrossRefPubMed
37.
go back to reference Nic Fhogartaigh CJ, Vargas-Prada S, Huancare V, Lopez S, Rodriguez J, Moore DA: Physician-initiated courtesy MODS testing for TB and MDR-TB diagnosis and patient management. Int J Tuberc Lung Dis. 2008, 12 (5): 555-560.PubMed Nic Fhogartaigh CJ, Vargas-Prada S, Huancare V, Lopez S, Rodriguez J, Moore DA: Physician-initiated courtesy MODS testing for TB and MDR-TB diagnosis and patient management. Int J Tuberc Lung Dis. 2008, 12 (5): 555-560.PubMed
38.
go back to reference Quezada CM, Kamanzi E, Mukamutara J, De Rijk P, Rigouts L, Portaels F, Amor YB: Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol. 2007, 45 (9): 3111-3114. 10.1128/JCM.00590-07.CrossRefPubMedPubMedCentral Quezada CM, Kamanzi E, Mukamutara J, De Rijk P, Rigouts L, Portaels F, Amor YB: Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol. 2007, 45 (9): 3111-3114. 10.1128/JCM.00590-07.CrossRefPubMedPubMedCentral
39.
go back to reference Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Rieder HL: Risk of occupational tuberculosis in National Tuberculosis Programme laboratories in Korea. Int J Tuberc Lung Dis. 2007, 11 (2): 138-142.PubMed Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Rieder HL: Risk of occupational tuberculosis in National Tuberculosis Programme laboratories in Korea. Int J Tuberc Lung Dis. 2007, 11 (2): 138-142.PubMed
40.
go back to reference Pepe M: Study design and Hypothesis testing. The Statistical Evaluation of Medical Tests for Classification and Prediction. Edited by: Pepe MS. 2004, Oxford Statistical Science Series, Oxford University Press, USA, Chapter 8: 218- Pepe M: Study design and Hypothesis testing. The Statistical Evaluation of Medical Tests for Classification and Prediction. Edited by: Pepe MS. 2004, Oxford Statistical Science Series, Oxford University Press, USA, Chapter 8: 218-
41.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003, 138 (1): W1-12.CrossRefPubMed Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003, 138 (1): W1-12.CrossRefPubMed
42.
go back to reference Martin A, Portaels F, Palomino JC: Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother. 2007, 59 (2): 175-183. 10.1093/jac/dkl477.CrossRefPubMed Martin A, Portaels F, Palomino JC: Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother. 2007, 59 (2): 175-183. 10.1093/jac/dkl477.CrossRefPubMed
43.
go back to reference Abate G, Aseffa A, Selassie A, Goshu S, Fekade B, WoldeMeskal D, Miorner H: Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2004, 42 (2): 871-873. 10.1128/JCM.42.2.871-873.2004.CrossRefPubMedPubMedCentral Abate G, Aseffa A, Selassie A, Goshu S, Fekade B, WoldeMeskal D, Miorner H: Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2004, 42 (2): 871-873. 10.1128/JCM.42.2.871-873.2004.CrossRefPubMedPubMedCentral
44.
go back to reference WoldeMeskel D, Abate G, Lakew M, Goshu S, Selassie A, Miorner H, Aseffa A: Evaluation of a direct colorimetric assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis. Ethop J Health Dev. 2005, 19 (1): 51-54. WoldeMeskel D, Abate G, Lakew M, Goshu S, Selassie A, Miorner H, Aseffa A: Evaluation of a direct colorimetric assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis. Ethop J Health Dev. 2005, 19 (1): 51-54.
45.
go back to reference Goloubeva V, Lecocq M, Lassowsky P, Matthys F, Portaels F, Bastian I: Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J Clin Microbiol. 2001, 39 (4): 1501-1505. 10.1128/JCM.39.4.1501-1505.2001.CrossRefPubMedPubMedCentral Goloubeva V, Lecocq M, Lassowsky P, Matthys F, Portaels F, Bastian I: Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J Clin Microbiol. 2001, 39 (4): 1501-1505. 10.1128/JCM.39.4.1501-1505.2001.CrossRefPubMedPubMedCentral
46.
go back to reference El-Sayed Zaki M, Goda T: Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. Tuberculosis (Edinb). 2007, 87 (2): 102-108. 10.1016/j.tube.2006.05.002.CrossRef El-Sayed Zaki M, Goda T: Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. Tuberculosis (Edinb). 2007, 87 (2): 102-108. 10.1016/j.tube.2006.05.002.CrossRef
Metadata
Title
Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
Authors
Freddie Bwanga
Sven Hoffner
Melles Haile
Moses L Joloba
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-67

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue